Literature DB >> 5154875

Inhibition by rifampin of African swine fever virus replication in tissue culture.

A H Dardiri, H L Bachrach, E Heller.   

Abstract

Vaccinia virus and African swine fever virus are deoxyribonucleic acid viruses of cytoplasmic origin. The fact that rifampin inhibits the replication of the former virus led to an investigation of its effect on African swine fever virus. The virus used was cytopathogenic to a PK-15 cell line, hemadsorbing in pig leukocyte cultures and lethal to pigs. Rifampin clearly inhibited the multiplication and cytopathogenicity of the virus in PK-15 cells. There was a 1- to 5-log reduction in virus titer depending upon the rifampin concentration, the multiplicity of infection, and the time after infection. Inhibition was greatest at a concentration of 200 mug of rifampin/ml. The drug was not viricidal per se, and the inhibition of virus replication was not due to the cell-granulating effect of rifampin since cultures which were transiently pretreated for long as 90 hr with 200 mug of drug/ml supported viral replication to the same degree as untreated cultures.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5154875      PMCID: PMC416260          DOI: 10.1128/iai.4.1.34-36.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  10 in total

1.  Biogenesis of vaccinia: separation of early stages from maturation by means of rifampicin.

Authors:  A Nagaya; B G Pogo; S Dales
Journal:  Virology       Date:  1970-04       Impact factor: 3.616

2.  Chemical structure of African swine fever virus investigated by electron microscopy.

Authors:  S S Breese; C J DeBoer
Journal:  J Gen Virol       Date:  1967-04       Impact factor: 3.891

3.  Selective inhibition of vaccinia virus by the antibiotic rifampicin.

Authors:  E Heller; M Argaman; H Levy; N Goldblum
Journal:  Nature       Date:  1969-04-19       Impact factor: 49.962

4.  New derivatives of rifamycin SV.

Authors:  N Maggi; R Pallanza; P Sensi
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

5.  Continual requirement for a host RNA polymerase component in a bacteriophage development.

Authors:  E P Geiduschek; J Sklar
Journal:  Nature       Date:  1969-03-01       Impact factor: 49.962

6.  Rifampicin--a new antitrachoma drug.

Authors:  Y Becker; Z Zakay-Rones
Journal:  Nature       Date:  1969-05-31       Impact factor: 49.962

7.  Rifampicin inhibits the growth of some mammalian viruses.

Authors:  J H Subak-Sharpe; M C Timbury; J F Williams
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

8.  Rifampicin and poxvirus replication.

Authors:  Z Ben-Ishai; E Heller; N Goldblum; Y Becker
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

9.  Rifapicin inhibition of trachoma agent in vivo.

Authors:  Y Becker; Y Asher; N Himmel; Z Zakay-Rones; B Maythar
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

10.  Growth Inhibition of Mycobacterium tuberculosis After Single-Pulsed Exposures to Streptomycin, Ethambutol, and Rifampin.

Authors:  W H Beggs; J W Jenne
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

  10 in total
  7 in total

1.  Failure of rifampin to inhibit frog polyhedral cytoplasmic deoxyribovirus multiplication.

Authors:  L S Kucera
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

2.  Failure of rifampin to inhibit adenovirus replication.

Authors:  D P McCormick; R P Wenzel; E P Smith; W E Beam
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

3.  Inhibition of African swine fever virus in cultured swine monocytes by phosphonoacetic acid (PAA) and by phosphonoformic acid (PFA).

Authors:  F Villinger; E V Genovesi; D J Gerstner; T C Whyard; R C Knudsen
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 4.  Cell Lines for the Development of African Swine Fever Virus Vaccine Candidates: An Update.

Authors:  Dionigia Meloni; Giulia Franzoni; Annalisa Oggiano
Journal:  Vaccines (Basel)       Date:  2022-04-29

5.  New agents active against African swine fever virus.

Authors:  A Sola; S Rodríguez; C Gil-Fernández; B Alarcón; M E González; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

6.  Comprehensive Analysis of G-Quadruplexes in African Swine Fever Virus Genome Reveals Potential Antiviral Targets by G-Quadruplex Stabilizers.

Authors:  Elishiba Muturi; Fei Meng; Huan Liu; Mengwei Jiang; Hongping Wei; Hang Yang
Journal:  Front Microbiol       Date:  2021-12-16       Impact factor: 5.640

Review 7.  Rifampicin for COVID-19.

Authors:  George D Panayiotakopoulos; Dimitrios T Papadimitriou
Journal:  World J Virol       Date:  2022-03-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.